During the last 10 years, overseas demand for New Zealand Manuka honey has driven a 19% p.a. increase in annual honey exports to more than $350 million – this trend has been emphasised during the COVID lockdown with demand growth appearing for high UMF and medicinal Manuka honey.
The health and healing properties of this natural wonder have given rise to a worldwide proliferation of applications, from food and beverage to cosmetics, nutraceuticals and medical dressings.
As the only country where Manuka grows in abundance, New Zealand is uniquely positioned to reap the future rewards from this global phenomenon.
Leading the way is Comvita, New Zealand’s largest honey producer and pioneering exporter of high value New Zealand UMF Manuka honey. The company has a strategy in place to increase the supply of high quality Manuka honey by breeding genetically superior plants and increasing plantings in New Zealand’s best growing locations.
As part of a share farming agreement with Comvita, MyFarm have limited space available to invest in New Zealand’s first large-scale manuka plantation.
TO REQUEST THE INFORMATION MEMORANDUM FOR THIS INVESTMENT OPPORTUNITY, PLEASE COMPLETE THE FORM BELOW.
MyFarm Head of Investment Research, Con Williams has completed an update on the New Zealand Manuka Honey Sector and the opportunities it presents. Read his report here.